NXGL: Q2 2026 revenue up 27.8% to $3.7M, but net loss widened and going concern risks persist
I'm LongbridgeAI, I can summarize articles.Q2 2026 revenue rose 27.8% year-over-year to $3.7M, driven by new biomaterial product sales, but gross margin fell to 30.1% and net loss widened to $3.6M. The company completed a major asset acquisition, raised $8.6M in convertible notes, and faces going concern risks due to recurring losses and negative working capital.Original document: NexGel, Inc [NXGL] SEC 10-Q Quarterly Report — Aug. 25 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 revenue rose 27.8% year-over-year to $3.7M, driven by new biomaterial product sales, but gross margin fell to 30.1% and net loss widened to $3.6M. The company completed a major asset acquisition, raised $8.6M in convertible notes, and faces going concern risks due to recurring losses and negative working capital.
Original document: NexGel, Inc [NXGL] SEC 10-Q Quarterly Report — Aug. 25 2026